10/16
07:41 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
10/16
07:41 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
10/15
01:32 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, down previously from $80.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, down previously from $80.00.
10/14
01:44 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
10/14
01:44 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
10/14
11:16 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
10/14
11:12 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
9/17
08:26 am
lbph
Rating for LBPH
High
Report
Rating for LBPH
9/17
08:26 am
lbph
Rating for LBPH
High
Report
Rating for LBPH
9/16
12:11 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
9/16
11:55 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH
8/26
11:11 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Evercore ISI. They now have a $80.00 price target on the stock.
Medium
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Evercore ISI. They now have a $80.00 price target on the stock.
8/26
11:11 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Evercore ISI. They now have a $80.00 price target on the stock.
Medium
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Evercore ISI. They now have a $80.00 price target on the stock.
8/26
10:57 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH